Business · 27/08/2002Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Clinical Holds Following Investigator Misconduct
Summary
The Food and Drug Administration (FDA) has published a draft guidance outlining its procedures for imposing clinical holds on clinical trials following the discovery of investigator misconduct, with the aim of protecting human subjects from harm.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →